Three of six companies from Kentucky
LOUISVILLE, Ky. (July 27, 2016) — XLerateHealth, a Louisville-based accelerator for early-stage healthcare companies, announced it has selected six companies to participate as part of its incoming 13-week intensive cohort program that begins Aug. 1.
Companies selected are:
eBlu Solutions (Louisville): A platform providing workflow-driven services to streamline the complex processes that specialty medical practices face while navigating a patient to treatment. Services include real-time benefit investigation, as well as management of prior authorization and manufacturer co-pay assistance workflows. eBlu supports practices in providing a better patient care experience, decreasing the time to treat while mitigating the financial risks a practice faces in providing in-office infusion.
OR Link (Lexington): OR Link is a mobile healthcare software company focused on redefining communication in and around the operating room. At its core, the unique software platform aims to simplify the process by which a surgeon’s “preferences” (for everything from surgical instruments to operating room layout) are stored, shared, and utilized in real time between all the personnel in the OR. Additional features include peri-operative scheduling management and surgical education.
Medic-Air (Louisville): A portable cooling device designed for children who suffer from the upper airway infection known as croup. The device is easy to use and on-demand, instantly producing an ambient temperature drop of 50 degrees to help shrink the airway inflammation the virus causes.
Epikardis Medical (Nashville): A medical device ideation and development company. Founded by a registered nurse and a mechanical engineer, Epikardis aims to create products that carry robust clinical and financial incentives. Their first product under development is a chest tube stabilization device that is expected to enter the market in 2017.
Orthopedix (Providence): A 3D-printed orthopedic implant company that creates personalized, patient-specific implants throughout the body. The implants are individually sized and shaped to fit to each patient’s unique anatomy, offering benefits not achievable with “off-the-shelf” orthopedic implants.
Solas Operations (Toronto): Uses a Raman spectroscopy based diagnostic for early, non-invasive identification of gout. Solas’ novel gout diagnostic is able to identify gout early in asymptomatic patients, which is superior to the other two methods currently used (ultrasound and clinical exam for diagnosis) which identifies gout only after the disease has progressed and the patient is symptomatic – which makes it much harder to treat.